Foundation Medicine, Sumitomo Partner On Acute Leukemia Therapy
18 Feb 2025 //
BUSINESSWIRE
Sumitomo Pharma Get Approval for Gemtesa in Overactive Bladder
23 Dec 2024 //
PR NEWSWIRE
Sumitomo Pharma Presents Data on Nuvisertib and Enzomenib at ASH
09 Dec 2024 //
PR NEWSWIRE